• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏非心肌细胞在心脏毒性药物作用下的功能和相互作用。

Cardiac Nonmyocyte Cell Functions and Crosstalks in Response to Cardiotoxic Drugs.

机构信息

Dipartimento di Medicina e Chirurgia, Università degli Studi di Salerno, via Salvatore Allende, 84081 Baronissi, Italy.

Dipartimento di Scienze Biomediche Avanzate, Università Federico II di Napoli, via Pansini 5, 80131 Napoli, Italy.

出版信息

Oxid Med Cell Longev. 2017;2017:1089359. doi: 10.1155/2017/1089359. Epub 2017 Oct 22.

DOI:10.1155/2017/1089359
PMID:29201269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5671742/
Abstract

The discovery of the molecular mechanisms involved in the cardiac responses to anticancer drugs represents the current goal of cardio-oncology research. The oxidative stress has a pivotal role in cardiotoxic responses, affecting the function of all types of cardiac cells, and their functional crosstalks. Generally, cardiomyocytes are the main target of research studies on cardiotoxicity, but recently the contribution of the other nonmyocyte cardiac cells is becoming of growing interest. This review deals with the role of oxidative stress, induced by anticancer drugs, in cardiac nonmyocyte cells (fibroblasts, vascular cells, and immune cells). The alterations of functional interplays among these cardiac cells are discussed, as well. These interesting recent findings increase the knowledge about cardiotoxicity and suggest new molecular targets for both diagnosis and therapy.

摘要

涉及抗癌药物引起的心脏反应的分子机制的发现,是当前心血管肿瘤学研究的目标。氧化应激在心脏毒性反应中起着关键作用,影响所有类型的心肌细胞及其功能串扰。一般来说,心肌细胞是心脏毒性研究的主要目标,但最近,其他非心肌细胞在心脏中的作用正引起越来越多的关注。这篇综述讨论了抗癌药物引起的氧化应激在心脏非心肌细胞(成纤维细胞、血管细胞和免疫细胞)中的作用。还讨论了这些心脏细胞之间功能相互作用的改变。这些有趣的最新发现增加了对心脏毒性的认识,并为诊断和治疗提供了新的分子靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e96/5671742/ae56b7b11119/OMCL2017-1089359.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e96/5671742/9f5bfb70750b/OMCL2017-1089359.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e96/5671742/e6127ee0d02d/OMCL2017-1089359.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e96/5671742/ae56b7b11119/OMCL2017-1089359.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e96/5671742/9f5bfb70750b/OMCL2017-1089359.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e96/5671742/e6127ee0d02d/OMCL2017-1089359.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e96/5671742/ae56b7b11119/OMCL2017-1089359.003.jpg

相似文献

1
Cardiac Nonmyocyte Cell Functions and Crosstalks in Response to Cardiotoxic Drugs.心脏非心肌细胞在心脏毒性药物作用下的功能和相互作用。
Oxid Med Cell Longev. 2017;2017:1089359. doi: 10.1155/2017/1089359. Epub 2017 Oct 22.
2
Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types.在人诱导多能干细胞衍生的心肌细胞中进行的结构和功能筛选能够准确识别多种药物类型的心脏毒性。
Toxicol Appl Pharmacol. 2015 May 15;285(1):51-60. doi: 10.1016/j.taap.2015.03.008. Epub 2015 Apr 2.
3
Molecular mechanisms of cardiotoxicity of gefitinib in vivo and in vitro rat cardiomyocyte: Role of apoptosis and oxidative stress.吉非替尼对大鼠体内外心肌细胞心脏毒性的分子机制:细胞凋亡和氧化应激的作用
Toxicol Lett. 2016 Jun 11;252:50-61. doi: 10.1016/j.toxlet.2016.04.011. Epub 2016 Apr 12.
4
Can ErbB2 overexpression protect against doxorubicin cardiotoxicity?erbB2过表达能否预防阿霉素心脏毒性?
Am J Physiol Heart Circ Physiol. 2015 Oct;309(8):H1235-6. doi: 10.1152/ajpheart.00647.2015. Epub 2015 Aug 21.
5
Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.Rac1 信号通过活性氧依赖和非依赖途径介导多柔比星诱导的心脏毒性。
Cardiovasc Res. 2013 Jan 1;97(1):77-87. doi: 10.1093/cvr/cvs309. Epub 2012 Oct 1.
6
New signal transduction paradigms in anthracycline-induced cardiotoxicity.蒽环类药物诱导心脏毒性中的新信号转导模式
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1916-25. doi: 10.1016/j.bbamcr.2016.01.021. Epub 2016 Jan 29.
7
Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts.Mrp1缺失增强阿霉素对新生小鼠心肌细胞和心脏成纤维细胞的细胞毒性作用。
Toxicol Sci. 2016 May;151(1):44-56. doi: 10.1093/toxsci/kfw021. Epub 2016 Jan 27.
8
JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes.JAK2/STAT3信号通路介导金属硫蛋白对阿霉素诱导的小鼠心肌细胞毒性的保护作用。
Int J Toxicol. 2016 May;35(3):317-26. doi: 10.1177/1091581815614261. Epub 2015 Nov 2.
9
A multi-parameter in vitro screen in human stem cell-derived cardiomyocytes identifies ponatinib-induced structural and functional cardiac toxicity.一项在人干细胞衍生心肌细胞中进行的多参数体外筛选鉴定出了波纳替尼诱导的心脏结构和功能毒性。
Toxicol Sci. 2015 Jan;143(1):147-55. doi: 10.1093/toxsci/kfu215. Epub 2014 Oct 10.
10
Assessment of herb-drug synergy to combat doxorubicin induced cardiotoxicity.评估草药-药物协同作用以对抗多柔比星引起的心脏毒性。
Life Sci. 2018 Jul 15;205:97-106. doi: 10.1016/j.lfs.2018.05.021. Epub 2018 May 9.

引用本文的文献

1
HER2-Targeted Therapy-From Pathophysiology to Clinical Manifestation: A Narrative Review.HER2靶向治疗——从病理生理学到临床表现:一篇叙述性综述
J Cardiovasc Dev Dis. 2023 Dec 6;10(12):489. doi: 10.3390/jcdd10120489.
2
Role of non-cardiomyocytes in anticancer drug-induced cardiotoxicity: A systematic review.非心肌细胞在抗癌药物所致心脏毒性中的作用:一项系统综述。
iScience. 2022 Oct 8;25(11):105283. doi: 10.1016/j.isci.2022.105283. eCollection 2022 Nov 18.
3
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection.

本文引用的文献

1
Mechanistic Role of Kinases in the Regulation of Mitochondrial Fitness.激酶在调节线粒体健康中的机制作用
Adv Exp Med Biol. 2017;982:521-528. doi: 10.1007/978-3-319-55330-6_26.
2
Functional Role of Mitochondria in Arrhythmogenesis.线粒体在心律失常发生中的功能作用。
Adv Exp Med Biol. 2017;982:191-202. doi: 10.1007/978-3-319-55330-6_10.
3
Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes.多柔比星通过上调心肌细胞中死亡受体介导的细胞凋亡诱导心脏毒性。
抗癌药物的心脏毒性:分子机制与心脏保护策略
Front Cardiovasc Med. 2022 Apr 15;9:847012. doi: 10.3389/fcvm.2022.847012. eCollection 2022.
4
Cardiac Tissue Engineering: Inclusion of Non-cardiomyocytes for Enhanced Features.心脏组织工程:纳入非心肌细胞以增强功能特性
Front Cell Dev Biol. 2021 May 25;9:653127. doi: 10.3389/fcell.2021.653127. eCollection 2021.
5
Physical Exercise: A Novel Tool to Protect Mitochondrial Health.体育锻炼:保护线粒体健康的新工具。
Front Physiol. 2021 Apr 27;12:660068. doi: 10.3389/fphys.2021.660068. eCollection 2021.
6
Sunitinib and Imatinib Display Differential Cardiotoxicity in Adult Rat Cardiac Fibroblasts That Involves a Role for Calcium/Calmodulin Dependent Protein Kinase II.舒尼替尼和伊马替尼在成年大鼠心脏成纤维细胞中表现出不同的心脏毒性,其中钙/钙调蛋白依赖性蛋白激酶II发挥了作用。
Front Cardiovasc Med. 2021 Feb 1;7:630480. doi: 10.3389/fcvm.2020.630480. eCollection 2020.
7
Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects.采用诱导多能干细胞衍生的心脏和肝细胞构建的微工程系统,用于评估药物不良反应。
Exp Biol Med (Maywood). 2021 Feb;246(3):317-331. doi: 10.1177/1535370220959598. Epub 2020 Sep 17.
8
NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases.NFkappaB 是炎症与心血管疾病相互作用的关键参与者。
Int J Mol Sci. 2019 Mar 30;20(7):1599. doi: 10.3390/ijms20071599.
9
A Novel Small Peptide Inhibitor of NFB, RH10, Blocks Oxidative Stress-Dependent Phenotypes in Cancer.一种新型的 NF-B 小分子抑制剂 RH10 可阻断癌症中氧化应激依赖性表型。
Oxid Med Cell Longev. 2018 Nov 4;2018:5801807. doi: 10.1155/2018/5801807. eCollection 2018.
Sci Rep. 2017 Mar 16;7:44735. doi: 10.1038/srep44735.
4
Cobalt Cardiomyopathy: A Critical Reappraisal in Light of a Recent Resurgence.钴中毒性心肌病:鉴于近期的再度出现进行的批判性重新评估
Circ Heart Fail. 2016 Dec;9(12). doi: 10.1161/CIRCHEARTFAILURE.116.003604.
5
Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking.抗肿瘤相关心脏毒性,小鼠模型中的形态功能方面:新型工具二维斑点追踪的作用
Onco Targets Ther. 2016 Nov 2;9:6785-6794. doi: 10.2147/OTT.S106528. eCollection 2016.
6
The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer Therapy.生物标志物在降低癌症治疗后心脏毒性风险中的作用
Biomark Cancer. 2016 May 23;8(Suppl 2):39-45. doi: 10.4137/BIC.S31798. eCollection 2016.
7
Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity.心脏成纤维细胞中突变的共济失调毛细血管扩张症调节阿霉素诱导的心脏毒性。
Cardiovasc Res. 2016 May 1;110(1):85-95. doi: 10.1093/cvr/cvw032. Epub 2016 Feb 9.
8
SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy.在蒽环类药物性心肌病模型中,SIRT1激活通过减少心脏纤维化来减轻舒张功能障碍。
Int J Cardiol. 2016 Feb 15;205:99-110. doi: 10.1016/j.ijcard.2015.12.008. Epub 2015 Dec 15.
9
Inflammatory and fibrotic processes are involved in the cardiotoxic effect of sunitinib: Protective role of L-carnitine.炎症和纤维化过程参与了舒尼替尼的心脏毒性作用:左旋肉碱的保护作用。
Toxicol Lett. 2016 Jan 22;241:9-18. doi: 10.1016/j.toxlet.2015.11.007. Epub 2015 Nov 12.
10
Risk factors for anthracycline-associated cardiotoxicity.蒽环类药物相关心脏毒性的危险因素。
Support Care Cancer. 2016 May;24(5):2173-2180. doi: 10.1007/s00520-015-3008-y. Epub 2015 Nov 12.